Medicine
Clarinex-d 12 Hour 2.5 mg/120 mg extended-release tablet
Clarinex-d 12 Hour 2.5 mg/120 mg extended-release tablet is a prescription medicine containing Desloratadine and Pseudoephedrine for oral use, marketed by Organon, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 25°C (77°F), excursions permitted to 15°–30°C (59°–86°F). Avoid…
Key facts
- Active ingredient (INN)
- Desloratadine and Pseudoephedrine
- Brand
- Clarinex-d 12 Hour
- Strength
- 2.5 mg/120 mg
- Dosage form
- Extended-release tablet
- Route
- Oral
- Packs
- 100 tablets
- Marketing authorisation holder
- Organon
- Manufacturer
- Organon
- Origin register
- US FDA, United States
- Storage
- Store at 25°C (77°F), excursions permitted to 15°–30°C (59°–86°F). Avoid exposure at or above 30°C (86°F). Protect from excessive moisture. Protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- R01BA52 Desloratadine and Pseudoephedrine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 June 2021
- Identifiers
- RxCUI 1112248, 1112250DailyMed set ID 1af66b7a-4ab8-40d8-abdd-22d3310228a8NDC 78206-120Application NDA021313
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet, extended release in 1 bottle, plastic | 78206-120-01 | Organon | 1 June 2021 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Desloratadine and Pseudoephedrine is a fixed-dose combination of a histamine-1 receptor antagonist and an alpha-adrenergic agonist indicated for relief of nasal and non-nasal symptoms of seasonal allergic rhinitis, among other approved uses. MedsAcross supplies Desloratadine and Pseudoephedrine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Desloratadine and PseudoephedrineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- CLARINEX-D 12 HOUR prescribing information (Organon) · U.S. National Library of Medicine, DailyMed
- Aerinaze: European public assessment report (EPAR) · European Medicines Agency
Need Clarinex-d 12 Hour 2.5 mg/120 mg extended-release tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.